A detailed history of Smartleaf Asset Management LLC transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 63 shares of TBPH stock, worth $593. This represents 0.0% of its overall portfolio holdings.

Number of Shares
63
Previous 237 73.42%
Holding current value
$593
Previous $1.97 Million 74.16%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$7.66 - $10.25 $1,332 - $1,783
-174 Reduced 73.42%
63 $510,000
Q2 2024

Aug 13, 2024

BUY
$8.29 - $9.92 $1,964 - $2,351
237 New
237 $1.97 Million

Others Institutions Holding TBPH

About Theravance Biopharma, Inc.


  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $629M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.